Why is KLA stock gaining today?

KLA Corporation stock rose 2.6% in morning trading as investors rotated back into the semiconductor process-control leader ahead of its fiscal first-quarter 2027 earnings announcement scheduled for October 28, with analysts broadly anticipating strong revenue and earnings growth driven by artificial intelligence infrastructure buildouts, high-bandwidth memory, and advanced packaging demand. The company had guided for first-quarter revenue of approximately $4.0 billion — a meaningful step up from the $3.66 billion reported in the prior quarter — giving the market a concrete target to rally toward.

The rebound also reflects a technical snapback from an unusually prolonged selloff: KLAC had fallen for ten consecutive sessions through mid-October, pushing the stock to a 52-week low of $107.20 and well below the analyst consensus price target of roughly $221. Morgan Stanley, which cut its price target to $227 earlier this month while maintaining an Overweight rating, still implies upside of more than 50% from current levels, and Weiss Ratings upgraded the stock to Buy on October 16, adding incremental institutional support.

On the competitive landscape, peer Lam Research reported record fiscal first-quarter 2027 results on October 21 — with revenue surging to $8.22 billion and management raising its wafer fabrication equipment spending outlook — providing a positive read-through for the entire semiconductor equipment sector and reinforcing confidence that KLA’s own report could deliver similarly strong numbers. The broader market offered a mild tailwind, with the S&P 500 and Nasdaq each adding roughly 0.3% today, while no major central bank announcements or macro data releases disrupted sentiment.

Together, these forces — pre-earnings optimism, a deeply discounted valuation relative to analyst targets, a favorable peer result from Lam Research, and a constructive if modest market backdrop — combined to lift KLAC off its recent lows and drive today’s recovery toward $149.40, though the stock remains far below its 52-week high of $307.37, leaving the October 28 earnings call as the critical near-term test for a more sustained recovery.